Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in Guinea pigs and sheep

Virologica Sinica

Volumn 26, Issue 3, 2011, Pages 190-197

  Shao, Jun Jun ^a,b   Wang, Jing Feng ^b   Chang, Hui Yun ^b   Liu, Ji Xing ^a,b  

^a GANSU AGRICULTURAL UNIVERSITY   (China)

^b AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

Author keywords

Epitope; Foot and mouth disease; Guinea pigs; Vaccine

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; RECOMBINANT VACCINE; EPITOPE; VIRUS ANTIBODY; VIRUS PROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; ASIA; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; DRUG SAFETY; ESCHERICHIA COLI; FEMALE; FOOT AND MOUTH DISEASE; GENE CONSTRUCT; GENE DELIVERY SYSTEM; GENE EXPRESSION; GUINEA PIG; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; SHEEP; VACCINE PRODUCTION; VIRUS GENE; VP1 GENE; ANIMAL; FOOT AND MOUTH DISEASE VIRUS; GENETICS; IMMUNOLOGY; SHEEP DISEASE; VIROLOGY;

ANIMALIA; CAVIA; FOOT-AND-MOUTH DISEASE VIRUS; FOOT-AND-MOUTH DISEASE VIRUS - TYPE ASIA 1; OVIS; OVIS ARIES;

ANIMALS; ANTIBODIES, VIRAL; EPITOPES; FEMALE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GUINEA PIGS; SHEEP; SHEEP DISEASES; VACCINES, SYNTHETIC; VIRAL PROTEINS; VIRAL VACCINES;

EID: 80053118780     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-011-3174-0     Document Type: Article

References (25)

1. Barteling S J, Vreeswijk J. 1991. Developments in foot-and-mouth disease vaccines. Vaccine, 9 (2): 75-88.
2. Beck E, Strohmaier K. 1987. Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination. J Virol, 61: 1621-1629. (Pubitemid 17069743)
3. Blanco E, Garcia-Briones M, Sanz-Parra A, et al. 2001. Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. J Virol, 75 (7): 3164-3174. (Pubitemid 32225880)
4. Brumeanu T D, Casares S, Dehazya P, et al. 1997. Presentation of a viral peptide assembled on the carbohydrate moieties of immunoglobulin does not require processing. Eur J Immunol, 27 (9): 2408-2416. (Pubitemid 27404328)
5. Brumeanu T D, Swiggard W J, Steinman R M, et al. 1993. Efficient loading of identical viral peptide onto class II molecules by antigenized immunoglobulin and influenza virus. J Exp Med, 178 (5): 1795-1799. (Pubitemid 23318460)
6. Cedillo-Barrón L, Foster-Cuevas M, Belsham G J, et al. 2001. Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase. J Gen Virol, 82: 1713-1724. (Pubitemid 32611513)
7. Chan E W C, Wong S C S, Cheng W Y, et al. 2001. An immunoglobulin G based chimeric protein induced foot-and-mouth disease specific immune response in swine. Vaccine, 19: 538-546.
8. Collen T, Dimmarchi R, Doel T R. 1991, A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J Immunol, 146: 749-755.
9. Doel T R. 2005. Natural and vaccine induced immunity to FMD. Curr Top Microbiol Immunol, 288: 103-131. (Pubitemid 39657080)
10. Doel T R. 2003. FMD vaccines. Virus Res, 91: 81-99. (Pubitemid 36078432)
11. Gerner W, Hammer S E, Wiesmüller K H, et al. 2009. Identification of major histocompatibility complex restriction and anchor residues of foot-and-mouth disease virus-derived bovine T-cell epitopes. J Virol, 83: 4039-4050.
12. Golde W T, Pacheco J M, Duque H, et al. 2005. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response. Vaccine, 23: 5775-5782. (Pubitemid 41668884)
13. Grubman M J, Baxt B. 2004. Foot and mouth disease. Clin Microbiol Rev, 17 (2): 465-493.
14. He C, Wang H, Wei H, et al. 2010. A recombinant truncated FMDV 3AB protein used to better distinguish between infected and vaccinated cattle. Vaccine, 28 (19): 3435-2439.
15. Kadkhodayan S, Knapp M S, Schmidt J J, et al. 2000. Cloning, Expression, and One-Step Purification of the Minimal Essential Domain of the Light Chain of Botulinum Neurotoxin Type A. Protein Expr Purif, 19: 125-130. (Pubitemid 30387903)
16. Mackay D K, Forsyth M A, Davies P R, et al. 1998. Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, non-structural proteins in ELISA. Vaccine, 16 (5): 446-459. (Pubitemid 28044162)
17. Rodriguez L L, Barrera J, Kramer E, et al. 2003. A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type O VP1 and a promiscuous T-helper epitope induces eptide-specific antibodies but fails to protect cattle against viral challenge. Vaccine, 21: 3751-3756. (Pubitemid 37338202)
18. Rodriguez L L, Grubman M. 2009. Foot and mouth disease virus vaccines. Vaccine, 27: D90-D94.
19. Shao J J, Wong C K, Lin T, et al. 2011. Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine. Clin Vaccine Immunol, 18 (1): 143-149.
20. Su C X, Duan X G, Wang X Q, et al. 2007. Heterologous of FMDV immunodominant epitopes and HSP70 in P.pastoris and the subesequent immune response in mice. Vet Mirobiol, 124: 256-263.
21. Sutmoller P, Barteling S S, Olascoaga R C, et al. 2003. Control and eradication of foot-and-mouth disease. Virus Res, 91 (1): 101-144. (Pubitemid 36082879)
22. Taboga O, Tami C, Carrillo E, et al. 1997. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J Virol, 71: 2606-2614. (Pubitemid 27119896)
23. van Lierop M J, Wagenaar J P, van Noort J M, et al. 1995. Sequences derived from the highly antigenic VP1 region 140 to 160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus. J Virol, 69: 4511-4514.
24. Yi J Z, Liu M Q, Zhu C Z, et al. 2004. Recombinant bivalent vaccine against foot-and-mouth disease virus serotype O/A infection in guinea pig. Acta Biochim Biophys Sin (Shanghai), 36 (9): 589-596.
25. Zaghouani H, Steinman R, Nonacs R, et al. 1993. Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule. Science, 259: 224-227. (Pubitemid 23041798)